Best Grants for Cancer Nonprofits in Kentucky

Nonprofit 501(c) organizations in Kentucky addressing nutrition and food security, healthcare access, STEM education, climate and nature, or cancer-related health equity can apply for the Community Solutions Challenge, with awards up to Up to US $30,000. Grants from Astrazeneca Foundation help community-based programs serving historically excluded and disenfranchised populations in selected U.S. states and territories.

The Mathers Charitable Foundation Grant focuses on advancing basic scientific research with the potential to transform human health. It supports institutions and investigators in fields such as immunology, cancer biology, and neuroscience while prioritizing impactful, foundational discoveries. The foundation empowers researchers to drive innovative solutions and foster meaningful contributions to science and society. Eligibility includes U.S.-based institutions and principal investigators with equipped labs, while ineligible entities include overseas institutions and private foundations.

Nonprofit, tax-exempt 501(c)(3) educational or research institutions in Kentucky conducting childhood cancer research with non-animal methods can apply for US $210,000 in support. With a mission to advance alternatives to animal-based science, Alternatives Research & Development Foundation funds non-clinical or pre-clinical projects that improve childhood cancer knowledge or treatment while validating innovative non-animal models.

Professional elderly blues musicians in Kentucky facing emergency medical or basic living expenses can receive assistance with costs like cancer treatments, transportation, home care, utilities, or burial needs. The Pinetop Perkins Foundation’s Pinetop Assistance League pays creditors directly and may help those whose work or health needs intersect with cancer-related care.

Nonprofit and other eligible U.S. organizations conducting cancer/oncology comparative clinical effectiveness research can apply for up to US $13,000,000 to improve cancer care across the continuum. With a mission to improve patient-centered healthcare decisions, Patient-Centered Outcomes Research Institute provides support for projects addressing screening barriers, treatment delivery, and survivorship needs, including work benefiting Kentucky communities.

Cancer research teams focused on improving prevention, early detection, treatment, or survivorship care for high-burden populations in the U.S., including Kentucky, can apply for up to US $50,000 in pilot funding. Focused on cancer/oncology, Indiana Clinical and Translational Sciences Institute supports IUSCCC member-led projects that generate practical, evidence-based strategies and interdisciplinary, translational solutions.

Kentucky cancer and health research organizations can access funding through Patient-Centered Outcomes Research Institute for retrospective, observational comparative clinical effectiveness studies using existing data sources. Eligible U.S. and foreign private or public entities may apply for up to US $2,000,000 to address cancer, maternal health, mental and behavioral health, rare diseases, pain, substance use, and related conditions.

Cancer research institutions and academic medical centers conducting translational oncology studies in Kentucky and nationwide can seek funding to run P50 SPORE research centers. National Institutes of Health supports state-of-the-art human cancer research, including prevention, early detection, diagnosis, and treatment projects, with awards of US $25,000,000 for organ-specific or biologically related cancers.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education who reside in Macon, Moultrie, or Piatt County may be eligible for tuition and professional development support, including certifications and conferences. Heart of Illinois Community Foundation reviews applications monthly for studies in cancer-related fields, which may benefit organizations and individuals connected to cancer care in Kentucky through regional ties.

Full-time faculty clinicians in radiation oncology conducting cancer research in Kentucky can seek multi-year career development support through this national Clinician Scientist Development Grant. Focused on cancer and oncology, the American Cancer Society and American Society for Radiation Oncology provide US $135,000 annually to help clinician scientists become independent investigators while maintaining clinical practice.

Practicing radiation oncologists conducting cancer research relevant to improving health across the cancer continuum can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, offering US $729,000 over three to five years. Kentucky cancer nonprofits may benefit when affiliated clinicians secure this American Society for Radiation Oncology and American Cancer Society support.

Kentucky cancer and healthcare-focused nonprofits, hospitals, medical schools, and patient advocacy groups can access funding through Incyte for programs that provide healthcare information and support patients with cancer and other diseases. Eligible projects include medical education, professional training, nursing, and patient care initiatives that align with Incyte’s commitment to improving patient lives.

Cancer-focused hospitals, medical schools, patient advocacy groups, and other 501(c)(3) organizations in Kentucky can seek support for healthcare information and education initiatives. Focused on improving the lives of patients with cancer and other diseases, Incyte invites healthcare-related charitable contribution, sponsorship, and membership requests that meet its compliance and regulatory guidelines.

Cancer research institutions and oncology-focused organizations in Kentucky and across North America can seek funding for studies on combining radiation therapy with immunotherapy. With a mission to advance innovative cancer treatment, Radiation Oncology Institute provides support for projects exploring treatment optimization, toxicity reduction, education, and access to combined radiotherapy–immunotherapy, offering US $50,000 - US $100,000 over two years.

The Radiation Oncology Institute (ROI) Innovation Awards, offered by the American Society for Radiation Oncology, aim to accelerate innovative ideas in radiation therapy. Currently accepting applications for the 2026 awards, the program focuses on optimizing the combination of radiation therapy and immunotherapy to enhance cancer treatment outcomes. By supporting practical research, ROI strives to transform clinical practices and improve patient care in the fight against cancer.

Pfizer is offering a grant opportunity for independent medical education initiatives focused on Muscle Invasive Bladder Cancer (MIBC). This program aims to address the current knowledge gaps among healthcare professionals regarding emerging treatment data and its potential impact on clinical practices. By collaborating with Astellas, Pfizer seeks proposals that enhance awareness and understanding of the evolving MIBC landscape, ultimately improving patient outcomes in this critical area of unmet medical need.

The Joyce Bytof Memorial Cancer Survivors Scholarship, established by Joyce Bytof in collaboration with the American Cancer Society, supports childhood cancer survivors graduating from specific Wisconsin high schools. This scholarship aims to assist them in pursuing higher education despite the financial and academic challenges posed by their experiences. Joyce's legacy continues to inspire hope and resilience among young survivors as they strive for academic success and a brighter future.

The AACR-Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant supports innovative research on upper gastrointestinal malignancies, which are responsible for over one million deaths globally in 2023. This grant encourages collaboration between U.S. and Asian institutions, focusing on resistance, metastasis, and novel treatment strategies. Proposals should detail plans for clinical translation and are open to researchers at all career stages, especially those new to upper GI cancer research.

Bristol Myers Squibb Foundation Inc supports independent medical education to enhance healthcare professional competence and improve patient health outcomes. Their mission is to be a global leader in innovative medical education, focusing on evidence-based activities that address critical gaps in knowledge. By fostering excellence in healthcare, they aim to ensure measurable improvements in performance and patient outcomes across various disease areas.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The American Heart Association is seeking proposals to study the prevalence and treatment of cardiovascular, kidney, and metabolic diseases among cancer patients and survivors. Given the over 16.7 million cancer survivors in the U.S., this research aims to highlight critical health disparities, identify treatment modalities, and explore shared risk factors. Applications focusing on underrepresented populations and utilizing real-world data sources are especially encouraged, aiming to improve health outcomes in this vulnerable group.

The ASCO Clinical Oncology & Research Experience (ASCO CORE) offers medical students immersive exposure to the field of oncology through shadowing experiences in clinical and research settings. With two distinct tracks, participants can gain insights into patient care or research practices, guided by mentors. Eligible students must be enrolled in a U.S. DO or MD program and maintain a good academic record. This program aims to inspire the next generation of oncology professionals.

Grants Program for Penn Investigators - Faculty Awards

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Faculty Awards

Faculty awards are for two years with a funding level up to $200,000 per year.

Grants Program for Penn Investigators - Early career awards for Fellows, Postdocs and Instructors

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Early career awards for Fellows, Postdocs and Instructors

Early career awards for Fellows, Postdocs and Instructors up to $100,000 for one year. Grants are eligible for competitive renewal upon reapplication and are contingent on progress the first year.

The CORE Funding: AHNS Presidential Award supports innovative research that integrates emerging technologies in head and neck cancer studies. This initiative aims to address critical gaps in early detection and treatment, especially for patients with advanced disease. By leveraging tools such as AI and advanced imaging, the program seeks to enhance understanding of disease mechanisms and improve patient-centered intervention strategies, ultimately advancing the field of otolaryngology.

The National Cancer Institute (NCI) invites applications for the Toward Translation of Nanotechnology Cancer Interventions (TTNCI) program. This funding opportunity focuses on advanced pre-clinical research aimed at developing nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards will support the maturation of innovative nanomedicines using nanoparticles and nano-devices, enhancing cancer treatment efficacy. Successful projects will progress towards further NCI translational programs, such as the NExT initiative.

The NCI Pathway to Independence Award (K99/R00) aims to support talented postdoctoral researchers in their transition to independent faculty positions. This program provides essential NCI research funding to help awardees establish competitive, independent research careers. Applications must be submitted by 5:00 PM local time of the applicant's organization, ensuring timely consideration for this critical funding opportunity.